Striatal dopamine release and impaired reinforcement learning in adults with 22q11.2 deletion syndrome

Eur Neuropsychopharmacol. 2018 Jun;28(6):732-742. doi: 10.1016/j.euroneuro.2018.03.005. Epub 2018 Apr 25.

Abstract

22q11.2 deletion syndrome (22q11DS) is a genetic disorder caused by a microdeletion on chromosome 22q11.2 and associated with an increased risk for developing psychosis. The catechol-O-methyltransferase (COMT) gene is located in the deleted region and involved in dopamine (DA) breakdown. Impaired reinforcement learning (RL) is a recurrent feature in psychosis and thought to be related to abnormal striatal DA function. This study aims to examine RL and the potential association with striatal DA-ergic neuromodulation in 22q11DS. Twelve non-psychotic adults with 22q11DS and 16 healthy controls (HC) were included. A dopamine D2/3 receptor [18F]fallypride positron emission tomography (PET) scan was acquired while participants performed a modified version of the probabilistic stimulus selection task. RL-task performance was significantly worse in 22q11DS compared to HC. There were no group difference in striatal nondisplaceable binding potential (BPND) and task-induced DA release. In HC, striatal task-induced DA release was positively associated with task performance, but no such relation was found in 22q11DS subjects. Moreover, higher caudate nucleus task-induced DA release was found in COMT Met hemizygotes relative to Val hemizygotes. This study is the first to show impairments in RL in 22q11DS. It suggests that potentially motivational impairments are not only present in psychosis, but also in this genetic high risk group. These deficits may be underlain by abnormal striatal task-induced DA release, perhaps as a consequence of COMT haplo-insufficiency.

Keywords: 22q11DS; COMT; Dopamine; PET; Reinforcement learning.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Benzamides / pharmacokinetics
  • Brain Mapping
  • Catechol O-Methyltransferase / genetics
  • Corpus Striatum / diagnostic imaging
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism*
  • DiGeorge Syndrome / complications*
  • DiGeorge Syndrome / genetics
  • DiGeorge Syndrome / pathology*
  • Dopamine / metabolism*
  • Dopamine D2 Receptor Antagonists / pharmacokinetics
  • Female
  • Fluorodeoxyglucose F18 / pharmacokinetics
  • Humans
  • Intelligence Tests
  • Learning Disabilities / etiology*
  • Magnetic Resonance Imaging
  • Male
  • Methionine / genetics
  • Middle Aged
  • Mutation / genetics
  • Positron-Emission Tomography
  • Reinforcement, Psychology*
  • Task Performance and Analysis
  • Valine / genetics

Substances

  • Benzamides
  • Dopamine D2 Receptor Antagonists
  • Fluorodeoxyglucose F18
  • Methionine
  • COMT protein, human
  • Catechol O-Methyltransferase
  • fallypride
  • Valine
  • Dopamine